Heart and blood vessel health after childhood anthracycline treatment
Part of Cancer, Heart & circulation clinical trials.
This study looks at how the heart and blood vessels are working years after childhood cancer treatment with anthracycline chemotherapy, which can sometimes affect the heart. By checking your heart function, the study aims to find any early signs of problems so that better care can be provided.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with cancer between birth and your 16th birthday.
- You are at least 6 years old now.
- You received anthracycline chemotherapy (a common type of cancer drug) as part of your treatment.
- You have been cancer-free for at least 1 year.
- You had no known heart disease before receiving anthracycline therapy and have no congenital heart defects.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at children and teens who had cancer treatment to find early signs of heart problems. It helps doctors understand how to protect their hearts in the future.
This study tests whether a supervised exercise program can help keep your heart strong and improve your fitness while you are receiving chemotherapy with drugs called anthracyclines. Participating may help you feel better and reduce some side effects on your heart.
This study checks how a common chemotherapy drug (anthracycline) affects the heart in children. It will monitor heart function during treatment to help protect young patients.
This study looks at how chemotherapy and other cancer treatments affect the heart in children. It aims to find heart problems early so they can be treated quickly.
This study follows patients receiving a type of chemotherapy called anthracyclines to track how it affects the heart over time. The goal is to learn how to better protect heart health during cancer treatment.
This study uses heart imaging scans and blood tests to check if a common cancer drug (anthracycline) is affecting your heart during treatment. Early detection might help doctors protect your heart health.
Hear when a new Chemotherapeutic Toxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.